# Efficacy of Pancrelipase on Postprandial Belching and Bloating.

> **NCT00266721** · PHASE3 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 45 (—)

## Conditions studied

- Postprandial Bloating
- Postprandial Belching
- Postprandial Eructation

## Interventions

- **DRUG:** Pancrelipase (Creon) 2 tablets with each meal

## Key facts

- **NCT ID:** NCT00266721
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** —
- **Final completion:** 2000-10
- **Target enrollment:** 45 (—)
- **Last updated:** 2005-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00266721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00266721, "Efficacy of Pancrelipase on Postprandial Belching and Bloating.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00266721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*